1-Oleoyl lysophosphatidic acid: A new mediator of emotional behavior in rats

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Castilla Ortega, Estela ^a   Escuredo, Leticia ^b   Bilbao, Ainhoa ^a   Pedraza, Carmen ^a   Orio, Laura ^a,b   Estivill Torrús, Guillermo ^a   Santín, Luis J ^a   De Fonseca, Fernando Rodríguez ^a,b   Pavón, Francisco Javier ^a  

^a Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina IBIMA Plataforma Bionand   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 OLEOYL LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID; PROTEIN C FOS; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; ELEVATED PLUS MAZE TEST; EMOTION; FEEDING BEHAVIOR; FOOD INTAKE; FORCED SWIM TEST; HABITUATION; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PERIAQUEDUCTAL GRAY MATTER; PHENOTYPE; PROTEIN EXPRESSION; RAT; Y-MAZE TEST;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; EMOTIONS; FEEDING BEHAVIOR; LYSOPHOSPHOLIPIDS; MALE; MAZE LEARNING; MOTOR ACTIVITY; PERIAQUEDUCTAL GRAY; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RECEPTORS, LYSOPHOSPHATIDIC ACID;

EID: 84893967776     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085348     Document Type: Article

References (69)

1. Aoki J, Taira A, Takanezawa Y, Kishi Y, Hama K, et al. (2002) Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 277: 48737-48744.
2. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, et al. (2010) LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 50: 157-186.
3. Sato K, Malchinkhuu E, Muraki T, Ishikawa K, Hayashi K, et al. (2005) Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources. J Neurochem 92: 904-914.
4. Aoki J, Inoue A, Okudaira S (2008) Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 1781: 513-518.
5. Sano T, Baker D, Virag T, Wada A, Yatomi Y, et al. (2002) Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J Biol Chem 277: 21197-21206.
6. Choi JW, Chun J (2013) Lysophospholipids and their receptors in the central nervous system. Biochim Biophys Acta 1831: 20-32.
7. Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH (2010) International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev 62: 579-587.
8. Noguchi K, Herr D, Mutoh T, Chun J (2009) Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 9: 15-23.
9. Ye X, Ishii I, Kingsbury MA, Chun J (2002) Lysophosphatidic acid as a novel cell survival/apoptotic factor. Biochim Biophys Acta 1585: 108-113.
10. Bandoh K, Aoki J, Taira A, Tsujimoto M, Arai H, et al. (2000) Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. FEBS Lett 478: 159-165.
11. Estivill-Torrus G, Llebrez-Zayas P, Matas-Rico E, Santin L, Pedraza C, et al. (2008) Absence of LPA1 signaling results in defective cortical development. Cereb Cortex 18: 938-950.
12. Hecht JH, Weiner JA, Post SR, Chun J (1996) Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J Cell Biol 135: 1071-1083.
13. Dubin AE, Bahnson T, Weiner JA, Fukushima N, Chun J (1999) Lysophosphatidic acid stimulates neurotransmitter-like conductance changes that precede GABA and L-glutamate in early, presumptive cortical neuroblasts. J Neurosci 19: 1371-1381.
14. Trimbuch T, Beed P, Vogt J, Schuchmann S, Maier N, et al. (2009) Synaptic PRG-1 modulates excitatory transmission via lipid phosphate-mediated signaling. Cell 138: 1222-1235.
15. Pilpel Y, Segal M (2006) The role of LPA1 in formation of synapses among cultured hippocampal neurons. J Neurochem 97: 1379-1392.
16. Dash PK, Orsi SA, Moody M, Moore AN (2004) A role for hippocampal Rho- ROCK pathway in long-term spatial memory. Biochem Biophys Res Commun 322: 893-898.
17. Weiner JA, Hecht JH, Chun J (1998) Lysophosphatidic acid receptor gene vzg- 1/lpA1/edg-2 is expressed by mature oligodendrocytes during myelination in the postnatal murine brain. J Comp Neurol 398: 587-598.
18. Contos JJ, Fukushima N,Weiner JA, Kaushal D, Chun J (2000) Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci U S A 97: 13384-13389.
19. Handford EJ, Smith D, Hewson L, McAllister G, Beer MS (2001) Edg2 receptor distribution in adult rat brain. Neuroreport 12: 757-760.
20. Veloso A, Fernandez R, Astigarraga E, Barreda-Gomez G, Manuel I, et al. (2011) Distribution of lipids in human brain. Anal Bioanal Chem 401: 89-101.
21. Nagai J, Uchida H, Matsushita Y, Yano R, Ueda M, et al. (2010) Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine. Mol Pain 6: 78.
22. Matas-Rico E, Garcia-Diaz B, Llebrez-Zayas P, Lopez-Barroso D, Santin L, et al. (2008) Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus. Mol Cell Neurosci 39: 342-355.
23. Shin TJ, Kim HJ, Kwon BJ, Choi SH, Kim HB, et al. (2012) Gintonin, a ginseng-derived novel ingredient, evokes long-term potentiation through Nmethyl- D-aspartic acid receptor activation: involvement of LPA receptors. Mol Cells 34: 563-572.
24. Blanco E, Bilbao A, Luque-Rojas MJ, Palomino A, Bermudez-Silva FJ, et al. (2012) Attenuation of cocaine-induced conditioned locomotion is associated with altered expression of hippocampal glutamate receptors in mice lacking LPA1receptors. Psychopharmacology (Berl) 220: 27-42.
25. Castilla-Ortega E, Hoyo-Becerra C, Pedraza C, Chun J, Rodriguez De Fonseca F, et al. (2011) Aggravation of chronic stress effects on hippocampal neurogenesis and spatial memory in LPA(1) receptor knockout mice. PLoS One 6: e25522.
26. Castilla-Ortega E, Pedraza C, Chun J, de Fonseca FR, Estivill-Torrus G, et al. (2012) Hippocampal c-Fos activation in normal and LPA(1)-null mice after two object recognition tasks with different memory demands. Behav Brain Res 232: 400-405.
27. Castilla-Ortega E, Sanchez-Lopez J, Hoyo-Becerra C, Matas-Rico E, Zambrana- Infantes E, et al. (2010) Exploratory, anxiety and spatial memory impairments are dissociated in mice lacking the LPA1 receptor. Neurobiol Learn Mem 94: 73-82.
28. Garcia-Fernandez M, Castilla-Ortega E, Pedraza C, Blanco E, Hurtado- Guerrero I, et al. (2012) Chronic immobilization in the malpar1 knockout mice increases oxidative stress in the hippocampus. Int J Neurosci 122: 583-589.
29. Santin LJ, Bilbao A, Pedraza C, Matas-Rico E, Lopez-Barroso D, et al. (2009) Behavioral phenotype of maLPA1-null mice: increased anxiety-like behavior and spatial memory deficits. Genes Brain Behav 8: 772-784.
30. Pedraza C, Sanchez-Lopez J, Castilla-Ortega E, Rosell-Valle C, Zambrana- Infantes E, et al. (2013) Fear extinction and acute stress reactivity reveal a role of LPA receptor in regulating emotional-like behaviors. Brain Struct Funct.
31. Callaerts-Vegh Z, Leo S, Vermaercke B, Meert T, D'Hooge R (2012) LPA(5) receptor plays a role in pain sensitivity, emotional exploration and reversal learning. Genes Brain Behav.
32. Yoshida K, Nishida W, Hayashi K, Ohkawa Y, Ogawa A, et al. (2003) Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Circulation 108: 1746-1752.
33. Vahidy WH, Ong WY, Farooqui AA, Yeo JF (2006) Effects of intracerebroventricular injections of free fatty acids, lysophospholipids, or platelet activating factor in a mouse model of orofacial pain. Exp Brain Res 174: 781-785.
34. Alen F, Crespo I, Ramirez-Lopez MT, Jagerovic N, Goya P, et al. (2013) Ghrelin-induced orexigenic effect in rats depends on the metabolic status and is counteracted by peripheral CB1 receptor antagonism. PLoS One 8: e60918.
35. Navarro M, Rodriquez de Fonseca F, Alvarez E, Chowen JA, Zueco JA, et al. (1996) Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake. J Neurochem 67: 1982-1991.
36. Gomez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, et al. (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22: 9612-9617.
37. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. Sydney: Academic Press.
38. Drago F, Pedersen CA, Caldwell JD, Prange AJ, Jr. (1986) Oxytocin potently enhances novelty-induced grooming behavior in the rat. Brain Res 368: 287-295.
39. Nishikawa H, Hata T, Itoh E, Funakami Y (2004) A role for corticotropinreleasing factor in repeated cold stress-induced anxiety-like behavior during forced swimming and elevated plus-maze tests in mice. Biol Pharm Bull 27: 352-356.
40. Zarrindast M, Rostami P, Sadeghi-Hariri M (2001) GABA(A) but not GABA(B) receptor stimulation induces antianxiety profile in rats. Pharmacol Biochem Behav 69: 9-15.
41. Leussis MP, Bolivar VJ (2006) Habituation in rodents: a review of behavior, neurobiology, and genetics. Neurosci Biobehav Rev 30: 1045-1064.
42. Takahashi LK, Kalin NH, Vanden Burgt JA, Sherman JE (1989) Corticotropinreleasing factor modulates defensive-withdrawal and exploratory behavior in rats. Behav Neurosci 103: 648-654.
43. Navarro M, Hernandez E, Munoz RM, del Arco I, Villanua MA, et al. (1997) Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport 8: 491-496.
44. Navarro M, de Miguel R, Rodriguez de Fonseca F, Ramos JA, Fernandez-Ruiz JJ (1996) Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats. Behav Brain Res 75: 91-98.
45. Castagne V, Moser P, Roux S, Porsolt RD (2011) Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci Chapter 8: Unit 8 10A.
46. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229: 327-336.
47. Reyes-Cabello C, Alen F, Gomez R, Serrano A, Rivera P, et al. (2012) Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration. Pharmacol Biochem Behav 101: 1-7.
48. Santin LJ, Aguirre JA, Rubio S, Begega A, Miranda R, et al. (2003) c-Fos expression in supramammillary and medial mammillary nuclei following spatial reference and working memory tasks. Physiol Behav 78: 733-739.
49. Gundersen HJ (1988) The nucleator. J Microsc 151: 3-21.
50. Ramos A (2008) Animal models of anxiety: do I need multiple tests? Trends Pharmacol Sci 29: 493-498.
51. Ramos A, Pereira E, Martins GC, Wehrmeister TD, Izidio GS (2008) Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial. Behav Brain Res 193: 277-288.
52. Britton DR, Koob GF, Rivier J, Vale W (1982) Intraventricular corticotropinreleasing factor enhances behavioral effects of novelty. Life Sci 31: 363-367.
53. Dulawa SC, Holick KA, Gundersen B, Hen R (2004) Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29: 1321-1330.
54. HeiligM,McLeod S, Brot M, Heinrichs SC, Menzaghi F, et al. (1993) Anxiolyticlike action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8: 357-363.
55. Brandao ML, Troncoso AC, de Souza Silva MA, Huston JP (2003) The relevance of neuronal substrates of defense in the midbrain tectum to anxiety and stress: empirical and conceptual considerations. Eur J Pharmacol 463: 225-233.
56. Graeff FG (2004) Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 28: 239-259.
57. Ryan PJ, Ma S, Olucha-Bordonau FE, Gundlach AL (2011) Nucleus incertus- an emerging modulatory role in arousal, stress and memory. Neurosci Biobehav Rev 35: 1326-1341.
58. Hogg S, Michan L, Jessa M (2006) Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety. Neuropharmacology 51: 141-145.
59. Sela VR, Biesdorf C, Ramos DH, Zangrossi H, Jr., Graeff FG, et al. (2011) Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated Tmaze. Neurosci Lett 495: 63-66.
60. Jimenez-Velazquez G, Lopez-Munoz FJ, Fernandez-Guasti A (2010) Parallel anxiolytic-like and antinociceptive actions of diazepam in the anterior basolateral amygdala and dorsal periaqueductal gray. Brain Res 1349: 11-20.
61. Litvin Y, Pentkowski NS, Blanchard DC, Blanchard RJ (2007) CRF type 1receptors in the dorsal periaqueductal gray modulate anxiety-induced defensive behaviors. Horm Behav 52: 244-251.
62. Casarotto PC, de Bortoli VC, Correa FM, Resstel LB, Zangrossi H, Jr. (2010) Panicolytic-like effect of BDNF in the rat dorsal periaqueductal grey matter: the role of 5-HT and GABA. Int J Neuropsychopharmacol 13: 573-582.
63. Harrison SM, Reavill C, Brown G, Brown JT, Cluderay JE, et al. (2003) LPA1receptor-deficient mice have phenotypic changes observed in psychiatric disease. Mol Cell Neurosci 24: 1170-1179.
64. Roberts C, Winter P, Shilliam CS, Hughes ZA, Langmead C, et al. (2005) Neurochemical changes in LPA1 receptor deficient mice-a putative model of schizophrenia. Neurochem Res 30: 371-377.
65. Hill CS, Wynne J, Treisman R (1995) The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81: 1159-1170.
66. Muscella A, Elia MG, Greco S, Storelli C, Marsigliante S (2003) Activation of P2Y2 receptor induces c-FOS protein through a pathway involving mitogenactivated protein kinases and phosphoinositide 3-kinases in HeLa cells. J Cell Physiol 195: 234-240.
67. Tsuda T, Hamamori Y, Yamashita T, Fukumoto Y, Takai Y (1986) Involvement of three intracellular messenger systems, protein kinase C, calcium ion and cyclic AMP, in the regulation of c-fos gene expression in Swiss 3T3 cells. FEBS Lett 208: 39-42.
68. Saitoh A, Yamada M, Kobayashi S, Hirose N, Honda K, et al. (2006) ROCK inhibition produces anxiety-related behaviors in mice. Psychopharmacology (Berl) 188: 1-11.
69. Xiao Z, Jaiswal MK, Deng PY, Matsui T, Shin HS, et al. (2012) Requirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior. Hippocampus 22: 1438-1450.